Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Daicel ( (JP:4202) ) has issued an update.
Daicel Corporation announced corrections to its consolidated financial results for the fiscal year ended March 31, 2025. The corrections pertain to errors found in the investment in equity method investees under the segment information of the financial statements. These adjustments are crucial for accurate financial reporting and may impact stakeholders’ understanding of the company’s financial health.
The most recent analyst rating on (JP:4202) stock is a Buy with a Yen2040.00 price target. To see the full list of analyst forecasts on Daicel stock, see the JP:4202 Stock Forecast page.
More about Daicel
Daicel Corporation operates in the chemical industry, focusing on producing a range of products including medical and healthcare materials, smart safety materials, engineering plastics, and other specialized chemicals. The company is listed on the Prime Market of the Tokyo Stock Exchange and has a diverse market focus, catering to various industrial needs.
Average Trading Volume: 684,408
Technical Sentiment Signal: Sell
Current Market Cap: Yen315.7B
See more insights into 4202 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue